OTC Markets Group Welcomes Bayer AG to OTCQX

Core Insights - Bayer AG has been upgraded to trade on the OTCQX Best Market, moving from the Pink market, which enhances its visibility and accessibility for U.S. investors [1][3] - The upgrade signifies Bayer's commitment to transparency and adherence to high financial standards and corporate governance practices [3][4] - Bayer's operations span Pharmaceuticals, Consumer Health, and Crop Science, aligning with its mission of "Health for all, Hunger for none" [4] Company Overview - Bayer AG is a global enterprise focused on life sciences, particularly in health care and nutrition, employing approximately 93,000 people and generating sales of 46.6 billion euros in fiscal 2024 [4] - The company invests significantly in research and development, with R&D expenses amounting to 6.2 billion euros [4] Market Context - The OTCQX Market provides a platform for companies listed on qualified international exchanges to offer transparent trading to U.S. investors, utilizing their home market reporting [3] - OTC Markets Group Inc. operates regulated markets for trading 12,000 U.S. and international securities, facilitating efficient access to the U.S. financial markets [5][6]